Last reviewed · How we verify
NCT07303504
Preparation for Sports Retirement: Study Protocol
NA trial testing Psychoeducational Programme in Sport Retirement in 26 participants. Not yet recruiting.
1 February 2027
Quick facts
| Lead sponsor | University of Salamanca |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 26 |
| Start date | 1 February 2026 |
| Primary completion | 1 February 2027 |
| Estimated completion | 1 May 2027 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Psychoeducational Programme
- Education Programme
Conditions studied
- Sport Retirement — all drugs for Sport Retirement →
- Psychoeducation — all drugs for Psychoeducation →
- Retirement — all drugs for Retirement →
- Adaptation — all drugs for Adaptation →
Sponsor
University of Salamanca
Who can join
Eligibility, any sex, with Sport Retirement or Psychoeducation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: This article presents the protocol for a randomised controlled trial designed to develop and evaluate a psychoeducational intervention aimed at preparing high-performance athletes for the challenges and opportunities presented by the transition to retirement from sport. The protocol was developed through a literature review and consultations with experts in sports psychology and career transition. Methods: The study will be conducted at the Faculty of Psychology of the University of Salamanca (Spain). High-performance athletes aged 30 or older who are close to retirement or who have retired in the last five years will be recruited. Participants will be randomly assigned to two groups: the intervention group, which will undergo a psychoeducational programme consisting of 12 sessions over 3 months; and the control group, which will receive a minimum educational programme of one session. All participants will complete initial and final assessments, as well as a 3-month follow-up, collecting sociodemographic data and applying various psychological, social and health assessment instruments. Discussion: This protocol describes a comprehensive psychoeducational intervention aimed at improving quality of life and attitudes towards retirement from sport, increasing life satisfaction, psychological flexibility, perceived social support, general health, self-efficacy and self-regulation, and reducing negative stereotypes associated with the end of a sporting career. The evidence generated will guide future interventions, policies, and educational programmes to promote a healthy, active, and satisfying transition to the post-sport stage.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07303504
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Psychoeducational Programme
Trials testing the same drug.
- NCT06533202 — Psycho-educational Intervention Programme for Comprehensive Preparation for Retirement: Study Protocol · NA · not yet recruiting
- NCT06461104 — Physical Activity in People With Borderline Personality Disorder (PABORD) · NA · not yet recruiting
Other University of Salamanca trials
Trials by the same sponsor.
- NCT07359495 — Multicomponent Training and Muscle Quality in Older Women · NA · not yet recruiting
- NCT07286539 — Precision Physical Exercise for Personalized Onco-Hematology. · NA · not yet recruiting
- NCT07387770 — Muscle Deterioration in Hospitalized Cancer Patient · NA · not yet recruiting
- NCT07387757 — Exergames in Mental Health · NA · not yet recruiting
- NCT07333768 — EQUISOCK: New Antiequine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07303504 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Salamanca
- Last refreshed: 31 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07303504.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing